about | Maps & Directions | contact | admissions | faculty | alumni & development | library | Tech Support Center | dean's office | Policies & Procedures

FAculty directory

Back to alphabetical index



Ron Schey, MD, FACGron schey, md, facg


Associate Professor, Medicine

Telephone: 215-707-9900

Email: ron.schey@tuhs.temple.edu



Department of Medicine, Section of Gastroenterology




Educational Background:


MD, Sackler Faculty of Medicine, Tel Aviv, Israel, 1991


Internship, Sapir Medical Center, Tel Aviv University, Kfar-Saba, Israel, 1993


Residency, Sapir Medical Center, Tel Aviv University, Kfar-Saba, Israel, 1997


Fellowship, Gastroenterology & Hepatology, Edith Wolfson Medical Center, Holon, Israel, 2000


Fellowship, Neurogastroenterology, VA Medical Center, University of Arizona, Tucson, Arizona, 2007


Return to top



clinical Interests:

  • Esophageal disorders - gastroesophageal reflux disease (GERD), Barrett's esophagus, motility disorders, non-cardiac chest pain, eosinophilic esophagitis
  • Gastroparesis
  • Pelvic floor disorders, constipation, incontinence

Return to top



board certifications:


  • Internal Medicine

Return to top



professional affiliations:

  • Israel Medical Association
  • American Gastroenterological Association
  • American College of Gastroenterology
  • American Neurogastroenterology & Motility Society

Return to top




Recent Medically Related Publications, Obtained from PubMed (Click on PubMed ID to view abstract)

26504868. Iorio N, Bernstein GR, Malik Z, Schey R, Acute Esophageal Necrosis Presenting With Henoch-Schönlein Purpura. ACG Case Rep J 3:1(17-9)2015 Oct

26283236. Reichenbach ZW, Sloan J, Rizvi-Toner A, Bayman L, Valestin J, Schey R, A 4-week Pilot Study With the Cannabinoid Receptor Agonist Dronabinol and Its Effect on Metabolic Parameters in a Randomized Trial. Clin Ther 37:10(2267-74)2015 Oct 1

26209079. Malamood M, Schey R, Diminished quality of life in non-cardiac chest pain: A cause as much as an effect. Rev Gastroenterol Mex 80:2(119-20)2015 Apr-Jun

26089696. Iorio N, Malik Z, Schey R, Profile of rifaximin and its potential in the treatment of irritable bowel syndrome. Clin Exp Gastroenterol 8:(159-67)2015

25956704. Singla R, Homko C, Schey R, Parkman HP, Diabetes-related autoantibodies in diabetic gastroparesis. Dig Dis Sci 60:6(1733-7)2015 Jun

25840923. Wytiaz V, Homko C, Duffy F, Schey R, Parkman HP, Foods provoking and alleviating symptoms in gastroparesis: patient experiences. Dig Dis Sci 60:4(1052-8)2015 Apr

25803402. Shin GH, Toto EL, Schey R, Pregnancy and postpartum bowel changes: constipation and fecal incontinence. Am J Gastroenterol 110:4(521-9; quiz 530)2015 Apr

25729555. Wilson N, Schey R, Lubiprostone in constipation: clinical evidence and place in therapy. Ther Adv Chronic Dis 6:2(40-50)2015 Mar

25715910. Malik Z, Baik D, Schey R, The role of cannabinoids in regulation of nausea and vomiting, and visceral pain. Curr Gastroenterol Rep 17:2(429)2015 Feb

24918010. Frederickson NW, Bayman L, Valestin J, Redd M, Lee YJ, Soubra M, Schey R, Lack of seasonal variation in the incidence of eosinophilic oesophagitis in adolescent and adult non-PPI-responsive oesophageal eosinophilia midwestern US populations. United European Gastroenterol J 2:2(69-76)2014 Apr

24798996. Spengler EK, Dunkelberg J, Schey R, Alcoholic hepatitis: current management. Dig Dis Sci 59:10(2357-66)2014 Oct

24506238. Hasan Y, Go J, Hashmi SM, Valestin J, Schey R, Influence of everyday bolus consistencies in different body positions on high-resolution esophageal pressure topography (HREPT) parameters. Dis Esophagus 28:3(246-52)2015 Apr

24382218. Lee YJ, Redd M, Bayman L, Frederickson N, Valestin J, Schey R, Comparison of clinical features in patients with eosinophilic esophagitis living in an urban and rural environment. Dis Esophagus 28:1(19-24)2015 Jan

23855975. Haslem BD, Samuelson MI, Schey R, A case of eosinophilic esophagitis discovered with positron emission tomography imaging: a case report. J Med Case Rep 7:(187)2013 Jul 15

23001405. Redd M, Schey R, Eosinophilic esophagitis: current treatment. Dig Dis Sci 58:3(613-20)2013 Mar

22907620. Schey R, Cromwell J, Rao SS, Medical and surgical management of pelvic floor disorders affecting defecation. Am J Gastroenterol 107:11(1624-33; quiz p.1634)2012 Nov

24833931. Soubra M, Schey R, Lubiprostone for the treatment of adult women with irritable bowel syndrome with constipation. Clin Med Insights Gastroenterol 5:(23-30)2012

21780893. Schey R, Rao SS, The role of rifaximin therapy in patients with irritable bowel syndrome without constipation. Expert Rev Gastroenterol Hepatol 5:4(461-4)2011 Aug

21523369. Schey R, Rao SS, Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome. Dig Dis Sci 56:6(1619-25)2011 Jun

18797407. Schey R, Shapiro M, Navarro-Rodriguez T, Fass SS, Han B, Wendel C, Fass R, Comparison of the different characteristics of sensed reflux events among different heartburn groups. J Clin Gastroenterol 43:8(699-704)2009 Sep

18054551. Schey R, Dickman R, Parthasarathy S, Quan SF, Wendel C, Merchant J, Powers J, Han B, van Handel D, Fass R, Sleep deprivation is hyperalgesic in patients with gastroesophageal reflux disease. Gastroenterology 133:6(1787-95)2007 Dec

21960837. Schey R, Villarreal A, Fass R, Noncardiac chest pain: current treatment. Gastroenterol Hepatol (N Y) 3:4(255-62)2007 Apr

17183948. Schey R, Leichtmann G, Pomeranz I, Novis B, Konikoff F, [ERCP for benign disease in the elderly: a good prognosis]. Harefuah 145:11(795-7, 863)2006 Nov

15078482. Bruck R, Schey R, Aeed H, Hochman A, Genina O, Pines M, A protective effect of pyrrolidine dithiocarbamate in a rat model of liver cirrhosis. Liver Int 24:2(169-76)2004 Apr

11867181. Bruck R, Aeed H, Schey R, Matas Z, Reifen R, Zaiger G, Hochman A, Avni Y, Pyrrolidine dithiocarbamate protects against thioacetamide-induced fulminant hepatic failure in rats. J Hepatol 36:3(370-7)2002 Mar

11573870. Schey R, Avni Y, Bruck R, Shirin H, History of drug-induced hepatitis and risk of amoxicillin/clavulanate-induced hepatotoxicity. Ann Pharmacother 35:9(1142-3)2001 Sep

Return to top